Axon Enterprise could be set up for continued gains in the months ahead, according to Morgan Stanley.
Analyst Meta Marshall upgraded the stock to overweight, and her price target of $700 reflects about 10% upside from Monday's close.
This comes as the stock has risen more than 146% year to date.
"While the name is expensive and may need to grow into valuation given run YTD, over the long term, we see it as a core holding."
"As a result, we are more willing to ascribe value to AI portfolio pulling through other products, which could lead to additional valuation upside (as prelim AI portfolio pull through is likely built into price after recent run)," Marshall continued.
Persons:
Morgan Stanley, Meta Marshall, Marshall, FactSet –